BofA analyst Wamsi Mohan lowered the firm’s price target on Nutanix (NTNX) to $93 from $95 and keeps a Buy rating on the shares. Nutanix delivered fiscal Q4 results above guidance and its initial FY26 view is likely to be conservative given that management has historically guided conservatively in giving the first guidance for a year, the analyst tells investors. Nutanix has exceed operating margin guidance by 500 basis points, on average, over the past three years, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix price target lowered to $71 from $85 at Wells Fargo
- Nutanix: Strong Execution and Strategic Growth Drive Buy Rating
- Nutanix price target lowered to $81 from $90 at JPMorgan
- Positive Outlook and Buy Rating for Nutanix Driven by Strong Financial Performance and Strategic Partnerships
- Nutanix’s Strong Performance and Promising Prospects: Buy Rating Affirmed by Jason Ader